Providence Health System Adds Robotic Bronchoscopy Tool

Patients in Providence now have access to robotic technology that improves precision for lung biopsy and lesion targeting.

Updated on Oct. 26, 2026 in Asthma

A close-up view of a stainless steel robotic medical arm inside a modern, sterile hospital diagnostic suite.
CharterCARE Health has installed a new robotic-assisted bronchoscopy system at Roger Williams Medical Center in Providence to improve precision for lung biopsies. AI Illustration. Upload story photo >

Live Poll

Do you believe new robotic technology improves healthcare quality for patients in your community?

CharterCARE Health has introduced a new robotic-assisted bronchoscopy system at its facilities, including Roger Williams Medical Center in Providence. The technology helps clinicians more accurately biopsy and target small lung lesions.

Why it matters

Traditional bronchoscopy can struggle to reach and identify small lung tumors, potentially delaying diagnosis and treatment. This platform offers a more precise approach for patients undergoing lung screenings and biopsy procedures.

A study conducted at the Cleveland Clinic reported a 90% diagnostic success rate among 100 patient cases. It remains unknown how this diagnostic precision will impact long-term survival rates compared to existing standard bronchoscopic methods.

The players

CharterCARE Health

A health system managing Roger Williams Medical Center and Our Lady of Fatima Hospital.

Noah Medical

A medical device company that manufactures the Galaxy System robotic bronchoscopy platform.

The details

The Galaxy System, manufactured by Noah Medical, utilizes a robotic, adjustable arm paired with advanced imaging technology. This combination allows clinicians to navigate the complex structures of the lungs to reach and target small pulmonary lesions that were previously difficult to access. By improving the ability to biopsy these small areas, the system supports earlier intervention in lung cancer treatment.

Timeline

  1. March 2023: The Galaxy System received FDA clearance.

  2. October 21, 2026: CharterCARE Health announced the system implementation.

Health Landscape

The introduction of this robotic platform marks a shift in how medical centers approach the biopsy and treatment of small lung lesions. It follows the broader trend of integrating computer-assisted, flexible navigation tools into standard respiratory and oncology care.

If you are undergoing lung screenings or have been advised to have a biopsy for a pulmonary nodule, talk to your primary care physician about current diagnostic capabilities in your area. Ask whether robotic-assisted procedures are appropriate for your specific lung health situation.

The takeaway

Robotic-assisted bronchoscopy is evolving to provide higher diagnostic precision for lung tissue testing. Patients with concerns about lung health or upcoming imaging results should discuss the availability of advanced biopsy tools with their respiratory specialist or oncologist.

Further reading

For more information on respiratory health services, visit the Asthma section of our site.

Source note: This article includes information reported by Providence Business News.

Live Poll

Do you believe new robotic technology improves healthcare quality for patients in your community?